Oakbrook Investments LLC reduced its position in shares of CVS Health Corporation (NYSE:CVS) by 16.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,871 shares of the pharmacy operator’s stock after selling 950 shares during the period. Oakbrook Investments LLC’s holdings in CVS Health Corporation were worth $392,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of CVS. Cacti Asset Management LLC increased its stake in shares of CVS Health Corporation by 31.5% in the first quarter. Cacti Asset Management LLC now owns 491,195 shares of the pharmacy operator’s stock worth $38,731,000 after buying an additional 117,725 shares during the period. Integrated Investment Consultants LLC increased its stake in shares of CVS Health Corporation by 6.0% in the first quarter. Integrated Investment Consultants LLC now owns 2,670 shares of the pharmacy operator’s stock worth $210,000 after buying an additional 150 shares during the period. Atalanta Sosnoff Capital LLC increased its stake in shares of CVS Health Corporation by 1.0% in the first quarter. Atalanta Sosnoff Capital LLC now owns 30,202 shares of the pharmacy operator’s stock worth $2,371,000 after buying an additional 310 shares during the period. Triangle Securities Wealth Management increased its stake in shares of CVS Health Corporation by 1.4% in the first quarter. Triangle Securities Wealth Management now owns 27,313 shares of the pharmacy operator’s stock worth $2,144,000 after buying an additional 370 shares during the period. Finally, Cohen Lawrence B increased its stake in shares of CVS Health Corporation by 5.9% in the first quarter. Cohen Lawrence B now owns 59,513 shares of the pharmacy operator’s stock worth $4,672,000 after buying an additional 3,335 shares during the period. Institutional investors and hedge funds own 81.92% of the company’s stock.

Shares of CVS Health Corporation (NYSE:CVS) traded up 0.34% on Friday, reaching $79.41. The company’s stock had a trading volume of 2,985,502 shares. The stock has a 50-day moving average of $78.83 and a 200 day moving average of $78.96. The stock has a market capitalization of $80.73 billion, a price-to-earnings ratio of 15.82 and a beta of 0.91. CVS Health Corporation has a 52 week low of $69.30 and a 52 week high of $98.44.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The firm had revenue of $45.69 billion during the quarter, compared to analysts’ expectations of $45.36 billion. During the same period last year, the firm posted $1.32 EPS. The business’s revenue was up 4.5% on a year-over-year basis. On average, analysts expect that CVS Health Corporation will post $5.88 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 3rd. Investors of record on Monday, July 24th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Thursday, July 20th. This represents a $2.00 dividend on an annualized basis and a yield of 2.52%. CVS Health Corporation’s dividend payout ratio is 39.92%.

WARNING: This piece was posted by Watch List News and is the property of of Watch List News. If you are reading this piece on another website, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece can be read at https://www.watchlistnews.com/cvs-health-corporation-nysecvs-shares-sold-by-oakbrook-investments-llc/1479698.html.

CVS has been the subject of a number of research analyst reports. Tigress Financial initiated coverage on CVS Health Corporation in a report on Thursday, April 27th. They issued a “buy” rating for the company. Vetr downgraded CVS Health Corporation from a “buy” rating to a “hold” rating and set a $85.78 price target for the company. in a report on Thursday, April 27th. Evercore ISI reiterated an “outperform” rating and issued a $88.00 price target (up from $87.00) on shares of CVS Health Corporation in a report on Wednesday, May 3rd. ValuEngine downgraded CVS Health Corporation from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Finally, Jefferies Group LLC reiterated a “hold” rating and issued a $82.00 price target on shares of CVS Health Corporation in a report on Friday, June 9th. Eight analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. CVS Health Corporation has a consensus rating of “Buy” and an average target price of $91.27.

In related news, CFO David M. Denton sold 230,510 shares of the firm’s stock in a transaction on Monday, June 12th. The stock was sold at an average price of $80.00, for a total transaction of $18,440,800.00. Following the completion of the sale, the chief financial officer now directly owns 176,983 shares of the company’s stock, valued at approximately $14,158,640. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Helena Foulkes sold 20,332 shares of the firm’s stock in a transaction on Monday, June 19th. The shares were sold at an average price of $76.98, for a total value of $1,565,157.36. Following the sale, the executive vice president now directly owns 59,300 shares of the company’s stock, valued at $4,564,914. The disclosure for this sale can be found here. Insiders have sold a total of 271,175 shares of company stock valued at $21,632,597 over the last ninety days. Insiders own 0.61% of the company’s stock.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.